All News

Porträt Marcus Conrad_KI_Erweiterung für Typo3

Awards & Grants, Molecular Targets and Therapeutics, MCD,

Marcus Conrad Receives Fondation ARC Léopold Griffuel Award

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, has been honored with the 54th Fondation ARC Léopold Griffuel Award for Translational and Clinical Research. The award recognizes his pioneering…

Electron micrograph of apoptotic cells showing the formation of membranebound apoptotic bodies a hallmark of programmed cell death

Molecular Targets and Therapeutics, MCD,

Mapping How Cancer Cells Die – and Survive: A 25-Year Update on a Defining Hallmark of Cancer

A new review in Cell by Helmholtz Munich researchers and international collaborators reframes regulated cell death as a roadmap for the next generation of precision oncology. Publication coincides with the 25th anniversary of the seminal Hallmarks of…

Porträt Marcus Conrad Hochformat Background: HDC Indoor

Awards & Grants, Molecular Targets and Therapeutics, MCD,

Marcus Conrad Receives German Cancer Award 2026

Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich was awarded the German Cancer Award 2026 in the category “Experimental Research”, together with Prof. José Pedro Friedmann Angeli of the University of…

photosynthesis green pattern

Environmental Health, EPI, Molecular Targets and Therapeutics, IFE,

More Than Waste: Photorespiration Shapes the Plant Epigenome

Photorespiration has long been regarded as an energetically costly side reaction of photosynthesis, reducing plants’ net carbon gain. Now, researchers at Helmholtz Munich, in collaboration with Heidelberg University and the Technical University of…

Rendering of a Neuron on blue background and yellow light flashes

Awards & Grants, Molecular Targets and Therapeutics, VIRO,

Can Ancient Viral Remnants Trigger Alzheimer’s Disease?

Ancient viral remnants embedded in the human genome may be an overlooked driver of Alzheimer’s disease. Dr. Michelle Vincendeau at Helmholtz Munich is investigating how so-called endogenous retroviruses influence disease-relevant mechanisms in human…

Healthy gut bacteria concept with natural probiotics for immune support.

New Research Findings, Molecular Targets and Therapeutics, INET,

More Than Just Gut Cohabitants: How Gut Bacteria Control Immune Responses

Bacteria in the human gut can directly deliver proteins into human cells, actively shaping immune responses. Led by researchers at Helmholtz Munich, with participation from Ludwig Maximilians University (LMU), Aix Marseille University, Inserm, and…